HCHong-Yan Cai

Hong-Yan Cai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hong-Yan Cai has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • miR‐186 Regulates Septic Hyperinflammation and Predicts Sepsis

    by Xiangru Li, Hongyan Cai, Boyuan Wang, Weiwei Luo, Rui Jia, Shaoyan Si, Mei Hu, Xiaotong Lou

    Sepsis is a life‐threatening condition caused by infection‐induced immune dysregulation. Clinically distinguishing sepsis from infection remains to be a challenge due to overlapping clinical features. Although miR‐186 regulates cell proliferation and apoptosis, and was predicted to target immune‐related genes, its role in sepsis is unclear. We retrospectively enrolled 21 infected patients and 20 sepsis patients. The miR‐186 level in blood cells was detected using real‐time PCR. Cytokine concentrations and lymphocyte subpopulation proportions were determined using flow cytometry. Clinical data were retrieved from medical records. The diagnostic ability of miR‐186 was compared with procalcitonin and lactate using the receiver operating characteristic (ROC) curve. miR‐186 was inhibited in human umbilical vein endothelial cells (HUVECs) and mice, followed by measurement of cytokine expression using real‐time PCR and flow cytometry. The expression level of miR‐186 was significantly higher in septic patients than in infected patients. miR‐186 showed relatively better diagnostic performance for sepsis than procalcitonin and lactate. The in vitro assay showed that LPS enhanced miR‐186 expression under a dose‐dependent manner. In vitro miR‐186 inhibition in HUVECs inhibited IL‐1β, IL‐6, and IL‐8 expression. In vivo miR‐186 inhibition significantly lowered IL‐1β concentration and natural killer cell ratio. In this study, we found that miR‐186 is significantly upregulated in sepsis and plays a regulatory role in cytokine expression, highlighting its potential as a diagnostic biomarker for sepsis.

  • Apolipoprotein E4 Impairs in vivo Hippocampal Long-Term Synaptic Plasticity by Reducing the Phosphorylation of CaMKIIα and CREB

    by Feng Qiao, Xiu-Ping Gao, Li Yuan, Hong-Yan Cai, Jin-Shun Qi

    Inheritance of the apolipoprotein E genotype ε4 (APOE4) is a powerful risk factor for most cases of late-onset Alzheimer's disease (AD). However, the effects of ApoE4 on the long-term synaptic plasticity and its underlying mechanism have not clearly investigated. In the present study, we examined the effects of ApoE4 on the hippocampal late-phase long-term potentiation (L-LTP) and investigated its probable molecular mechanisms by using in vivo field potential recording, immunohistochemistry, and western blotting. The results showed that: (1) intra-hippocampal injection of 0.2 μg ApoE4, but not ApoE2, before high frequency stimulations (HFSs) attenuated the induction of hippocampal L-LTP in the CA1 region, while injection of the same concentration of ApoE4 after HFSs, even at a higher concentration (2 μg), did not affect the long term synaptic plasticity; (2) ApoE4 injection did not affect the paired pulse facilitation in the hippocampal CA1 region; (3) ApoE4 injection before, not after, HFSs significantly decreased the levels of phosphorylated Ca 2+ /calmodulin-dependent protein kinase IIα (p-CaMKIIα) and phosphorylated cAMP response element-binding protein (p-CREB) in the hippocampus. These results demonstrated for the first time that ApoE4 could impair hippocampal L-LTP by reducing p-CaMKIIα and p-CREB, suggesting that the ApoE4-induced suppression of hippocampal long-term synaptic plasticity may contribute to the cognitive impairments in genetic AD; and both CaMKIIα and CREB are important intracellular targets of the neurotoxic ApoE4.